Inolex ekwuputala ihe eji echekwa ihe wee nye European patent EP3075401B1 maka usoro paraben na-enweghị maka ihe ịchọ mma n'elu, ụlọ mposi na ọgwụ na-achọ octylhydroxamic acid na orthodiols.Ngwakọta multifunctional nke acid esters, yana ụzọ nke iji ihe ndị a eme ihe iji gbochie omume ha.uto nke microorganisms.
Ngwa kachasị ọhụrụ nke Inolex, Spectrastat CHA (INCI: adịghị adị), bụ 100% eke, ntụ ntụ, onye na-abụghị nkwụ chelating nke gụnyere n'ahịrị Spectrastat nke ngwaahịa nchekwa.
Ụlọ ọrụ ahụ na-ekwu na organic acids na chelating agents sitere na aki oyibo bụ isi iyi nke octylhydroxamic acid (CHA), nke na-anọgide na-arụ ọrụ na pH na-anọpụ iche ma na-egbochi uto nke yist na ebu na ngwakọta.
Dị ka ụlọ ọrụ ahụ si kwuo, ọtụtụ MCTD na-ejikọta ya na CHA maka nchekwa nchekwa dị irè, gụnyere caprylyl glycol, glyceryl caprylate na glyceryl caprylate.A kọwara nchikota ihe a na ichekwa ihe ịchọ mma dị mma na patent Inolex ewepụtara na nso nso a wee mepụta aha azụmaahịa Spectrastat.
Michael J. Fevola, Ph.D., osote onye isi oche nke nyocha na mmepe na Inolex, kwuru, sị, "Ihe nhazi na ụzọ anyị nwere na-emepụta usoro ihe eji eme ihe na-enye ndị na-emepụta ihe nhọrọ mgbe ha na-emepụta usoro nchekwa kachasị mma maka ngwaahịa ndị ahịa."
Oge nzipu: Eprel-18-2024